1042 related articles for article (PubMed ID: 34520463)
1. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
[TBL] [Abstract][Full Text] [Related]
3. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
[TBL] [Abstract][Full Text] [Related]
4. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K
PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987
[TBL] [Abstract][Full Text] [Related]
5. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial.
Semitala FC; Chaisson LH; Dowdy DW; Armstrong DT; Opira B; Aman K; Kamya M; Phillips PPJ; Yoon C
Trials; 2022 May; 23(1):399. PubMed ID: 35550621
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
[TBL] [Abstract][Full Text] [Related]
8. Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature Review.
de Siqueira-Filha NT; Legood R; Cavalcanti A; Santos AC
Value Health; 2018 Apr; 21(4):482-490. PubMed ID: 29680106
[TBL] [Abstract][Full Text] [Related]
9. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
Foster S; Godfrey-Faussett P; Porter J
AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
[TBL] [Abstract][Full Text] [Related]
10. New opportunities in tuberculosis prevention: implications for people living with HIV.
González Fernández L; Casas EC; Singh S; Churchyard GJ; Brigden G; Gotuzzo E; Vandevelde W; Sahu S; Ahmedov S; Kamarulzaman A; Ponce-de-León A; Grinsztejn B; Swindells S
J Int AIDS Soc; 2020 Jan; 23(1):e25438. PubMed ID: 31913556
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
[TBL] [Abstract][Full Text] [Related]
12. Implementation of systematic screening for tuberculosis disease and tuberculosis preventive treatment among people living with HIV attending antiretroviral treatment clinics in Ghana: a national pilot study.
Adusi-Poku Y; Addai L; Wadie B; Afutu FK; Bruce SAK; Baddoo NA; Wagaw ZA; Campbell JR; Merle CS; Frimpong Amenyo RP
BMJ Open; 2024 May; 14(5):e083557. PubMed ID: 38806436
[TBL] [Abstract][Full Text] [Related]
13. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI
Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis.
Roscoe C; Lockhart C; de Klerk M; Baughman A; Agolory S; Gawanab M; Menzies H; Jonas A; Salomo N; Taffa N; Lowrance D; Robsky K; Tollefson D; Pevzner E; Hamunime N; Mavhunga F; Mungunda H
BMC Public Health; 2020 Dec; 20(1):1838. PubMed ID: 33261569
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
[TBL] [Abstract][Full Text] [Related]
17. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
Laurence YV; Griffiths UK; Vassall A
Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
[TBL] [Abstract][Full Text] [Related]
18. Preventing tuberculosis with community-based care in an HIV-endemic setting: a modelling analysis.
Ross JM; Greene C; Broshkevitch CJ; Dowdy DW; van Heerden A; Heitner J; Rao DW; Roberts DA; Shapiro AE; Zabinsky ZB; Barnabas RV
J Int AIDS Soc; 2024 Jun; 27(6):e26272. PubMed ID: 38861426
[TBL] [Abstract][Full Text] [Related]
19. TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings.
Pathmanathan I; Ahmedov S; Pevzner E; Anyalechi G; Modi S; Kirking H; Cavanaugh JS
Int J Tuberc Lung Dis; 2018 Jun; 22(6):596-605. PubMed ID: 29862942
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
